LivaNova price target lowered to $55 from $57 at Baird
PremiumThe FlyLivaNova price target lowered to $55 from $57 at Baird
2M ago
LivaNova raises FY24 adjusted EPS view to $3.10-$3.20 from $3.05-$3.15
Premium
The Fly
LivaNova raises FY24 adjusted EPS view to $3.10-$3.20 from $3.05-$3.15
2M ago
LivaNova reports Q2 adjusted EPS 93c, consensus 78c
Premium
The Fly
LivaNova reports Q2 adjusted EPS 93c, consensus 78c
2M ago
LivaNova’s Annual Meeting Strengthens Shareholder Alignment
PremiumCompany AnnouncementsLivaNova’s Annual Meeting Strengthens Shareholder Alignment
3M ago
LivaNova: patient cohort preliminary results of Recover study did not meet PE
Premium
The Fly
LivaNova: patient cohort preliminary results of Recover study did not meet PE
4M ago
LivaNova price target raised to $80 from $75 at Mizuho
Premium
The Fly
LivaNova price target raised to $80 from $75 at Mizuho
5M ago
LivaNova reports Q1 adjusted EPS 73c, consensus 49c
PremiumThe FlyLivaNova reports Q1 adjusted EPS 73c, consensus 49c
5M ago
LivaNova announces Ahmet Tezel as chief innovation officer
Premium
The Fly
LivaNova announces Ahmet Tezel as chief innovation officer
5M ago
LivaNova jumps nearly 12% after saying  trial likely to meet primary endpoint
Premium
The Fly
LivaNova jumps nearly 12% after saying trial likely to meet primary endpoint
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100